Invention Grant
![Pyrrolo[2,3-D]pyrimidine derivatives](/docs/US/2015-05-19/US09035074B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo[2,3-D]pyrimidine derivatives
- Patent Title (中): 吡咯并[2,3-D]嘧啶衍生物
-
Application No.: US14183946Application Date: 2014-02-19
-
Publication No.: US09035074B2Publication Date: 2015-05-19
- Inventor: Matthew Frank Brown , Ashley Edward Fenwick , Mark Edward Flanagan , Andrea Gonzales , Timothy Allan Johnson , Neelu Kaila , Mark J. Mitton-Fry , Joseph Walter Strohbach , Ruth E. TenBrink , John David Trzupek , Rayomand Jal Unwalla , Michael L. Vazquez , Mihir D. Parikh
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent A. David Joran
- Main IPC: C07D207/18
- IPC: C07D207/18 ; C07D487/04 ; C07D519/00
![Pyrrolo[2,3-D]pyrimidine derivatives](/abs-image/US/2015/05/19/US09035074B2/abs.jpg.150x150.jpg)
Abstract:
Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.
Public/Granted literature
- US20140243312A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES Public/Granted day:2014-08-28
Information query
